Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CLGNCLGN
Showing 2 of 7 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in COLLPLANT BIOTECHNOLOGIES LT

CITADEL ADVISORS LLC holds 53,700 shares of CLGN (COLLPLANT BIOTECHNOLOGIES LT), worth $18,736 as of 2026-Q2. The position was increased (+67.0% shares).

Current Value

$18,736

Current Shares

53,700

Total Value Change

+$1,525

Total Shares Change

+21,535

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
53,700
+67.0%
$18,7360.0%$0.35
19
2026-Q1
New
32,165
-
$17,2110.0%$0.57
28

Other major holders of CLGN: ARK Investment Management LLC, BROWN ADVISORY INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used